Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.

Abstract

Concurrent hepatitis C virus (HCV), hepatitis delta virus (HDV), or human immunodeficiency virus (HIV) infection with chronic hepatitis B virus (HBV) appears to increase the risk of progressive liver disease including liver cirrhosis and hepatocellular carcinoma. There is a 10% prevalence of HCV infection in chronic HBV or HDV infection. Serological… (More)
DOI: 10.1007/s12072-008-9066-1

Topics

  • Presentations referencing similar topics